Does LORLATINIB Cause Neuropathy peripheral? 142 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Neuropathy peripheral have been filed in association with LORLATINIB (Lorbrena). This represents 2.6% of all adverse event reports for LORLATINIB.
142
Reports of Neuropathy peripheral with LORLATINIB
2.6%
of all LORLATINIB reports
3
Deaths
17
Hospitalizations
How Dangerous Is Neuropathy peripheral From LORLATINIB?
Of the 142 reports, 3 (2.1%) resulted in death, 17 (12.0%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Neuropathy peripheral Listed in the Official Label?
Yes, Neuropathy peripheral is listed as a known adverse reaction in the official FDA drug label for LORLATINIB.
What Other Side Effects Does LORLATINIB Cause?
Death (1,050)
Neoplasm progression (633)
Off label use (394)
Weight increased (306)
Hallucination (290)
Blood cholesterol increased (281)
Dyspnoea (223)
Oedema peripheral (198)
Oedema (195)
Fatigue (188)
What Other Drugs Cause Neuropathy peripheral?
LENALIDOMIDE (10,215)
BORTEZOMIB (4,067)
OXALIPLATIN (3,662)
DEXAMETHASONE (3,543)
PACLITAXEL (3,508)
LEVOFLOXACIN (2,619)
CIPROFLOXACIN (2,607)
FLUOROURACIL (2,605)
CYCLOPHOSPHAMIDE (2,565)
POMALIDOMIDE (2,382)
Which LORLATINIB Alternatives Have Lower Neuropathy peripheral Risk?
LORLATINIB vs LORMETAZEPAM
LORLATINIB vs LORNOXICAM
LORLATINIB vs LOSARTAN
LORLATINIB vs LOSARTAN\LOSARTAN
LORLATINIB vs LOTEPREDNOL ETABONATE